Cytosorbents Corp Files 8-K
Ticker: CTSO · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 8-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, regulation-fd
TL;DR
CYTOSORBENTS CORP FILED AN 8-K. NO MAJOR NEWS.
AI Summary
Cytosorbents Corporation filed an 8-K on February 25, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates routine corporate reporting, with no immediate material news or financial updates disclosed.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting purposes and does not contain any new material information that would significantly impact the company's risk profile.
Key Players & Entities
- Cytosorbents Corporation (company) — Registrant
- February 25, 2025 (date) — Date of Report
- MedaSorb Technologies CORP (company) — Former Company Name
- GILDER ENTERPRISES INC (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits as of February 25, 2025.
What is the exact name of the registrant?
The exact name of the registrant is CYTOSORBENTS CORPORATION.
In which state was Cytosorbents Corporation incorporated?
Cytosorbents Corporation was incorporated in Delaware.
What is the principal executive office address for Cytosorbents Corporation?
The principal executive office address is 305 College Road East, Princeton, New Jersey 08540.
Does this filing announce any new material events or financial results?
This filing primarily serves as a notification of Regulation FD Disclosure and the submission of financial statements and exhibits, without detailing specific new material events or financial results.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding Cytosorbents Corp (CTSO).